PROMIS NEUROSCIENCES INC. Diluted Shares Outstanding (Weighted Average)
PROMIS NEUROSCIENCES INC. (PMN) reported Diluted Shares Outstanding (Weighted Average) of 9.14 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- PROMIS NEUROSCIENCES INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 9.14M shares, a 555.81% increase year-over-year.
- PROMIS NEUROSCIENCES INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 6.53M shares, a 368.26% increase year-over-year.
- PROMIS NEUROSCIENCES INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was -104.21M shares.
- PROMIS NEUROSCIENCES INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 48.83M shares, a 62.42% increase year-over-year.
- PROMIS NEUROSCIENCES INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 1.76M shares, a 65.98% increase from fiscal 2024.
- PROMIS NEUROSCIENCES INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 1.06M shares, a 91.39% decline from fiscal 2023.
- PROMIS NEUROSCIENCES INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 12.29M shares, a 63.85% increase from fiscal 2022.
- PROMIS NEUROSCIENCES INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 7.50M shares, a 29.68% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 9.14M shares 10-Q · filed 2026-08-13 | 7.87M shares 10-Q · filed 2026-08-13 | -29.51M shares derived: average of 3 quarters · filed 2026-08-13 | -9.93M shares derived: average of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | 6.53M shares 10-Q · filed 2026-05-12 | -48.84M shares derived: average of 2 quarters · filed 2026-05-12 | -16.28M shares derived: average of 3 quarters · filed 2026-05-12 | -11.86M shares derived: average of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | -104.21M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -27.69M shares derived: average of 2 quarters · filed 2026-03-25 | -17.99M shares derived: average of 3 quarters · filed 2026-08-13 | 1.76M shares 10-K · filed 2026-03-25 | |||
| 2025-09-30 | 48.83M shares 10-Q · filed 2025-11-12 | 25.11M shares derived: average of 2 quarters · filed 2026-08-13 | 37.08M shares 10-Q · filed 2025-11-12 | -3.79M shares derived: average of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | 1.39M shares 10-Q · filed 2026-08-13 | 34.85M shares 10-Q · filed 2025-08-13 | 1.39M shares 10-Q · filed 2026-08-13 | 34.85M shares 10-Q · filed 2025-08-13 | -21.34M shares derived: average of 3 quarters · filed 2026-08-13 | -8.48M shares derived: average of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | 1.39M shares 10-Q · filed 2026-05-12 | 34.85M shares 10-Q · filed 2025-05-12 | -32.70M shares derived: average of 2 quarters · filed 2026-05-12 | -11.78M shares derived: average of 3 quarters · filed 2026-05-12 | -3.89M shares derived: average of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | -66.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -18.36M shares derived: average of 2 quarters · filed 2026-03-25 | -5.65M shares derived: average of 3 quarters · filed 2026-03-25 | 1.06M shares 10-K · filed 2026-03-25 | 26.46M shares 10-K · filed 2025-03-31 | ||
| 2024-09-30 | 30.07M shares 10-Q · filed 2025-11-12 | 24.92M shares derived: average of 2 quarters · filed 2025-11-12 | 23.68M shares 10-Q · filed 2025-11-12 | 22.24M shares derived: average of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | 19.77M shares 10-Q · filed 2025-08-13 | 19.54M shares 10-Q · filed 2025-08-13 | 19.63M shares derived: average of 3 quarters · filed 2025-08-13 | 17.82M shares derived: average of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | 19.53M shares 10-Q · filed 2025-05-12 | 19.56M shares derived: average of 2 quarters · filed 2025-05-12 | 17.16M shares derived: average of 3 quarters · filed 2025-05-12 | 15.02M shares derived: average of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | 19.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 15.98M shares derived: average of 2 quarters · filed 2025-03-31 | 13.51M shares derived: average of 3 quarters · filed 2025-03-31 | 12.29M shares 10-K · filed 2025-03-31 | |||
| 2023-09-30 | 12.37M shares 10-Q · filed 2024-11-14 | 10.48M shares derived: average of 2 quarters · filed 2024-11-14 | 9.86M shares 10-Q · filed 2024-11-14 | 9.49M shares derived: average of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | 8.58M shares 10-Q · filed 2024-08-08 | 8.58M shares 10-Q · filed 2024-08-08 | 8.53M shares derived: average of 3 quarters · filed 2024-08-08 | 8.19M shares derived: average of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | 8.58M shares 10-Q · filed 2024-05-14 | 8.50M shares derived: average of 2 quarters · filed 2024-05-14 | 8.07M shares derived: average of 3 quarters · filed 2024-05-14 | 7.85M shares derived: average of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | 8.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 7.81M shares derived: average of 2 quarters · filed 2024-04-01 | 7.60M shares derived: average of 3 quarters · filed 2024-04-01 | 7.50M shares 10-K · filed 2024-04-01 | |||
| 2022-09-30 | 7.20M shares 10-Q · filed 2023-11-14 | 7.20M shares derived: average of 2 quarters · filed 2023-11-14 | 7.20M shares 10-Q · filed 2023-11-14 | 7.20M shares derived: average of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | 7.20M shares 10-Q · filed 2023-08-14 | 7.20M shares 10-Q · filed 2023-08-14 | 7.20M shares derived: average of 3 quarters · filed 2023-08-14 | 6.88M shares derived: average of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | 7.20M shares 10-Q · filed 2023-05-15 | 7.20M shares derived: average of 2 quarters · filed 2023-05-15 | 6.78M shares derived: average of 3 quarters · filed 2023-05-15 | 6.36M shares derived: average of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | 7.21M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | 6.57M shares derived: average of 2 quarters · filed 2023-03-08 | 6.08M shares derived: average of 3 quarters · filed 2023-03-08 | 5.79M shares 10-K · filed 2023-03-08 | |||
| 2021-09-30 | 5.92M shares 10-Q · filed 2022-11-14 | 5.51M shares derived: average of 2 quarters · filed 2022-11-14 | 5.31M shares 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | 5.10M shares 10-Q · filed 2022-08-12 | 5.00M shares 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |